ArticleThe Kaohsiung journal of medical sciences2022

CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma.

Hong-Wei Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.